Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

610 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retinal toxicities of systemic anticancer drugs.
Arora S, Surakiatchanukul T, Arora T, Errera MH, Agrawal H, Lupidi M, Chhablani J. Arora S, et al. Among authors: chhablani j. Surv Ophthalmol. 2022 Jan-Feb;67(1):97-148. doi: 10.1016/j.survophthal.2021.05.007. Epub 2021 May 26. Surv Ophthalmol. 2022. PMID: 34048859 Review.
Clinical applications of choroidal imaging technologies.
Chhablani J, Barteselli G. Chhablani J, et al. Indian J Ophthalmol. 2015 May;63(5):384-90. doi: 10.4103/0301-4738.159861. Indian J Ophthalmol. 2015. PMID: 26139797 Free PMC article. Review.
State of science: Choroidal thickness and systemic health.
Tan KA, Gupta P, Agarwal A, Chhablani J, Cheng CY, Keane PA, Agrawal R. Tan KA, et al. Among authors: chhablani j. Surv Ophthalmol. 2016 Sep-Oct;61(5):566-81. doi: 10.1016/j.survophthal.2016.02.007. Epub 2016 Mar 12. Surv Ophthalmol. 2016. PMID: 26980268 Review.
Reply to choroidal thickness, correlations, and systemic disease.
Tan KA, Gupta P, Agarwal A, Chhablani J, Cheng CY, Keane PA, Agrawal R. Tan KA, et al. Among authors: chhablani j. Surv Ophthalmol. 2017 Mar-Apr;62(2):251-252. doi: 10.1016/j.survophthal.2016.11.006. Epub 2016 Nov 11. Surv Ophthalmol. 2017. PMID: 27840090 No abstract available.
Long-term safety and efficacy of ziv-aflibercept in retinal diseases.
Mansour AM, Ashraf M, Dedhia CJ, Charbaji A, Souka AAR, Chhablani J. Mansour AM, et al. Among authors: chhablani j. Br J Ophthalmol. 2017 Oct;101(10):1374-1376. doi: 10.1136/bjophthalmol-2016-309724. Epub 2017 Mar 7. Br J Ophthalmol. 2017. PMID: 28270485
Retinal Findings on OCT in Systemic Conditions.
Chhablani PP, Ambiya V, Nair AG, Bondalapati S, Chhablani J. Chhablani PP, et al. Among authors: chhablani j. Semin Ophthalmol. 2018;33(4):525-546. doi: 10.1080/08820538.2017.1332233. Epub 2017 Jun 22. Semin Ophthalmol. 2018. PMID: 28640657 Review.
Restorative retinal laser therapy: Present state and future directions.
Chhablani J, Roh YJ, Jobling AI, Fletcher EL, Lek JJ, Bansal P, Guymer R, Luttrull JK. Chhablani J, et al. Surv Ophthalmol. 2018 May-Jun;63(3):307-328. doi: 10.1016/j.survophthal.2017.09.008. Epub 2017 Oct 5. Surv Ophthalmol. 2018. PMID: 28987614 Review.
610 results